Skip to main content

Decision XIII/8: Essential-use nominations for non-Article 5 Parties for controlled substances for the year 2002 and beyond

The Thirteenth Meeting of the Parties decided in Dec. XIII/8:

  1. To note with appreciation the excellent work done by the Technology and Economic Assessment Panel and its Technical Options Committees;
  2. To authorize the levels of production and consumption necessary to satisfy essential uses of CFCs for metered-dose inhalers (MDIs) for asthma and chronic obstructive pulmonary disease and CFC-113 for torpedo maintenance as specified in Annex I to the report of the 13th Meeting of the Parties